logo
Select company
Select metric
$ -17.82MConsolidated Income
VS
Market
30
Sector
58
Industry
72
History
85
$ 2.95Close
$ 1.1 - $ 13.42 52-Week Range
Ticker Information

Ticker

TRAW

Company Name

TRAWS PHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TRAWS PHARMA INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TRAW - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -17.82M
3/31/2025$ -140.05M
12/31/2024$ -166.52M
9/30/2024$ -140.78M
6/30/2024$ -137.05M
3/31/2024$ -18.16M
12/31/2023$ -18.95M
9/30/2023$ -20.18M
6/30/2023$ -20.84M
3/31/2023$ -20.62M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TRAWS PHARMA INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -24.48M.
  • Over the past 5 years, TRAWS PHARMA INC's average Cons. Inc. has been $ -44.96M.
  • The median Cons. Inc. for TRAWS PHARMA INC during this period was $ -20.4M
  • TRAWS PHARMA INC reached its highest Cons. Inc. over the past 5 years at $ -15.36M.
  • The lowest Cons. Inc. recorded by TRAWS PHARMA INC in the same timeframe $ -166.52M

TRAWS PHARMA INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
CYCN : CYCLERION THERAPEUTICS INC $ -1.95MLGVN : LONGEVERON INC $ -18.54MBOLT : BOLT BIOTHERAPEUTICS INC $ -50.71MLYRA : LYRA THERAPEUTICS INC $ -38.84MXBIO : XENETIC BIOSCIENCES INC $ -3.08MBRTX : BIORESTORATIVE THERAPIES INC $ -10.72MTXMD : THERAPEUTICSMD INC $ -459KAPRE : APREA THERAPEUTICS INC $ -13.85MLPCN : LIPOCINE INC $ -4.51MTNON : TENON MEDICAL INC $ -12.66M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

TRAW - Consolidated Income, Last 5 years

$ -166.52M

Minimum

Dec 31, 2024

$ -15.36M

Maximum

Jun 30, 2022

$ -44.96M

Average

$ -20.4M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.08M with a standard deviation of $ 116.5M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.08M
median$ -2.07M
std$ 116.5M